跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HLA-binding peptides vaccine
首页
药物
HLA-binding peptides vaccine
HLA-binding peptides vaccine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
EP 4357454 A3
申请人: IMMATICS BIOTECHNOLOGIES GMBH
优先权: 2016
CN
EP
US
9 件公开
EP 4177264 A1
申请人: IMMATICS BIOTECHNOLOGIES GMBH
优先权: 2016
EP
US
6 件公开
US 10537624 B2
申请人: IMMATICS BIOTECHNOLOGIES GMBH
优先权: 2016
CN
US
2 件公开
US 10538573 B2
申请人: IMMATICS BIOTECHNOLOGIES GMBH
优先权: 2017
US
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
EP 3620168 A1
申请人: IMMATICS BIOTECHNOLOGIES GMBH
优先权: 2014
CN
EP
US
6 件公开
Formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or class II molecules for vaccine
US 9289478 B2
申请人: LEWANDROWSKI PETER
优先权: 2008
CN
US
5 件公开
Cancer Antigen Peptides Derived from Wt1
US 2008152631 A1
申请人: INT INST CANCER IMMUNOLOGY INC
优先权: 2004
US
4 件公开
PERSONALIZED CANCER VACCINES AND ADOPTIVE IMMUNE CELL THERAPIES
EP 3511425 A1
申请人: PERSIMMUNE INC
优先权: 2012
EP
US
2 件公开
Peptide Derived From Prostate-Related Protein As Cancer Vaccine Candidate For Prostate Cancer Patient Who Is Positive For Hla-A3 Super-Type Allele Molecule
US 2010184699 A1
申请人: ITOH KYOGO
优先权: 2005
US
TUMOUR-ASSOCIATED PEPTIDES BINDING TO HUMAN LEUKOCYTE ANTIGEN (HLA) CLASS I OR II MOLECULES AND RELATED ANTI-CANCER VACCINE
US 2009274714 A1
申请人: IMMATICS BOITECHNOLOGIES GMHH
优先权: 2005
US
Novel formulations of tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules for vaccines
CN 101648012 A
申请人: IMMATICS BIOTECHNOLOGIES GMBH
优先权: 2008
CN
Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines
CN 102573902 A
申请人: CT FOR MOLECULAR MEDICINE AND IMMUNOLOGY
优先权: 2010
CN
US 2011064754 A1
申请人: CT FOR MOLECULAR MEDICINE AND IMMUNOLOGY
优先权: 2010
US
Cross Protective Epitopes of Aspergillus Fumigatus and Candida Albicans
US 2013315920 A1
申请人: TOPP MAX S
优先权: 2010
US
第 1 / 2 页
上一页
下一页
药物
反馈